PUBLISHER: The Business Research Company | PRODUCT CODE: 1942706
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942706
Diabetes care devices are employed to monitor and manage blood glucose levels in individuals with diabetes.
The primary categories of diabetes care devices include blood glucose test strips, insulin pens, syringes, pumps and injectors, lancing devices and equipment, continuous glucose monitoring devices and equipment, and blood glucose meters. Insulin pens are devices equipped with a needle to administer insulin into the subcutaneous tissue. Expenditures can be classified as public or private, and the products utilized fall into the categories of instruments/equipment and disposables. Testing methods encompass both point-of-care (POC) testing and non-point-of-care (POC) testing, with diverse end-users, including hospitals and clinics, diagnostic laboratories, and others.
Tariffs are influencing the diabetes care devices market by increasing costs of imported sensors, semiconductors, microelectronics, plastic disposables, and medical-grade components used in glucose meters, CGM systems, and insulin pumps. Healthcare providers and device manufacturers in North America and Europe are most affected due to reliance on cross-border component sourcing, while Asia-Pacific faces higher costs in device assembly and exports. These tariffs are contributing to higher device prices and reimbursement pressures. However, they are also driving domestic manufacturing, localized supply chains, and innovation in cost-efficient diabetes monitoring and delivery solutions.
The diabetes care devices market research report is one of a series of new reports from The Business Research Company that provides diabetes care devices market statistics, including diabetes care devices industry global market size, regional shares, competitors with a diabetes care devices market share, detailed diabetes care devices market segments, market trends and opportunities, and any further data you may need to thrive in the diabetes care devices industry. This diabetes care devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The diabetes care devices market size has grown rapidly in recent years. It will grow from $73.91 billion in 2025 to $82.22 billion in 2026 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to rising global diabetes prevalence, improved access to glucose monitoring devices, expansion of outpatient diabetes care, increased awareness of self-monitoring practices, growing availability of disposable testing supplies.
The diabetes care devices market size is expected to see rapid growth in the next few years. It will grow to $130.76 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing demand for real-time glucose monitoring, rising adoption of closed-loop insulin systems, expansion of digital diabetes management platforms, growing focus on personalized diabetes care, increasing healthcare investments in chronic disease management. Major trends in the forecast period include increasing adoption of continuous glucose monitoring devices, rising use of smart insulin delivery systems, growing integration of mobile health platforms, expansion of connected diabetes management ecosystems, enhanced focus on patient-centric monitoring solutions.
Rising healthcare expenditures are expected to drive the growth of the diabetes care device market in the future. Healthcare expenditures refer to the total amount spent on healthcare services, products, and activities over a specific period, typically measured at the individual, community, national, or global level. The combination of increasing healthcare expenditures, improved access to healthcare services, and a rise in diabetes diagnoses contributes to higher investments in research and development. This, in turn, leads to advancements in diabetes care devices, including enhanced glucose monitoring systems, insulin delivery devices, and digital health solutions. For example, in June 2025, the Centers for Medicare & Medicaid Services (CMS), a US-based federal agency, reported that National Health Expenditure (NHE) increased by 7.5% to $4.9 trillion in 2023, equal to $14,570 per capita, and represented 17.6% of Gross Domestic Product (GDP). During the same year, hospital spending rose by 10.4% to $1,519.7 billion, accelerating from the 3.2% growth recorded in 2022. Therefore, the increase in healthcare expenditure is poised to fuel the growth of the diabetes care device market in the coming years.
Major companies operating in the diabetes care devices market are concentrating on the development of advanced solutions such as real-time glucose monitoring technology to improve accuracy, ease of use, and proactive disease management. Real-time glucose monitoring technology delivers continuous, automatic glucose readings and alerts, enabling people with diabetes to make timely decisions and lower health risks. For example, in August 2025, Abbott Laboratories, a US-based healthcare company, introduced the FreeStyle Libre 2 Plus, which provides minute-by-minute glucose readings directly to a compatible smartphone and includes optional alerts for high and low glucose levels. The device supports effective diabetes self-management by offering automatic notifications, historical data, and trend arrows without the need for routine fingerstick testing. It operates using near-field communication and Bluetooth connectivity, can be worn for up to 15 days, and allows caregivers to receive glucose information through connected digital health platforms. Overall, the device enhances patient safety by enabling rapid intervention and improves user engagement through real-time health insights that support everyday decision-making.
In September 2025, Glooko Inc., a US-based provider of remote patient monitoring platforms, digital diabetes management solutions, and connected device integration tools, acquired Monarch Medical Technologies for an undisclosed amount. Through this acquisition, Glooko plans to extend its connected diabetes care ecosystem into inpatient environments by integrating Monarch's insulin-dosing technology to establish a unified hospital-to-home glycemic management platform. Monarch Medical Technologies, a US-based company, supplies FDA-cleared inpatient glucose management software, including the EndoTool system designed to support precise, algorithm-based insulin dosing in hospital settings.
Major companies operating in the diabetes care devices market are Abbott Laboratories, Becton Dickinson and Company, Roche Holding AG, Medtronic plc, Dexcom Inc., Novo Nordisk A/S, Eli Lilly and Company, LifeScan Inc., Ascensia Diabetes Care, Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed AG, Terumo Corporation, Nipro Corporation, Owen Mumford Ltd., ARKRAY Inc., AgaMatrix Inc., Acon Laboratories Inc., HTL-STREFA S.A., Sanofi India Limited
North America was the largest region in the global diabetes care devices market in 2025. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the diabetes care devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The diabetes care devices market consists of sales of blood glucose monitoring devices, insulin delivery devices, smart insulin pens and others that are used for monitor and treat diabetes patient. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Diabetes Care Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses diabetes care devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for diabetes care devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diabetes care devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.